Christopher J . Destache, PharmD, FCCP, BCIDP

Department

Pharmacy Practice

Position

Professor

Books

• Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology
  Destache Christopher J., 159Impact of a Clinical Pharmacokinetic Service on Patients Treated with Aminoglycosides: A Cost-Benefit Analysis [Book Chapter] 2008

Articles

• Kovarova Martina, Correction to 2015

Publications

• Antibiotics (Basel)
  Destache Christopher J., Impact of Extracorporeal Membrane Oxygenation (ECMO) on Serum Concentrations of Cefepime
  13:11, p. 1024 2024
• Jizba Theresa, A comparison of clinical outcomes associated with dosing metronidazole every 8 hours versus every 12 hours: a systematic review and metaanalysis 2024
• Wisconsin medical journal (Madison, Wis.)
  Azeem Ahad, Incidence and Prognosis of Pneumothorax and Pneumomediastinum in Hospitalized Patients With COVID-19 Pneumonia
  122:5, p. 337 2023
• Open forum infectious diseases
  Vivekanandan Renuga, 185. Pseudomonas aeruginosa (PA) Bacteremia and Patient Outcome during COVID-19 Pandemic
  10:Supplement_2 2023
• Open forum infectious diseases
  Reiche William, 2507. Sex and race disparities in hepatocellular carcinoma surveillance in patients with chronic hepatitis B: a single center retrospective review
  10:Supplement_2 2023
• Chest
  Wittenberg ZACHARIAH L, A RETROSPECTIVE EVALUATION OF THE SAFETY OF DEXMEDETOMIDINE IN NON-INTUBATED INTENSIVE CARE UNIT (ICU) PATIENTS
  164:4, p. A1596 - A1597 2023
• Chest
  Singal SRISHTI, A RETROSPECTIVE EVALUATION OF THE DISCONTINUATION RATE OF QUETIAPINE IN ICU PATIENTS
  164:4, p. A1607 2023
• Chest
  Isern RAUL, IMPACT OF EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) ON PLASMA CONCENTRATIONS OF CEFEPIME
  164:4, p. A1615 2023
• Microorganisms (Basel)
  Swaney Richard, Diagnosis and Outcomes of Fungal Co-Infections in COVID-19 Infections: A Retrospective Study
  11:9, p. 2326 2023
• Diagnostic microbiology and infectious disease
  Destache Christopher J, Assessment of the impact of centralized bioMérieux BACT/ALERT® VIRTUO® blood culture system (VIRTUO) implementation on outcomes in patients with gram-negative bacteremia, p. 116085 2023
• International journal of infectious diseases
  Patel Shiv, Discharge disposition and clinical outcomes of patients hospitalized with COVID-19
  130, p. 1 - 5 2023
• Journal of medicinal chemistry
  Bhattarai Pankaj, Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity
  66:1, p. 170 - 187 2023
• Critical care medicine
  Macaraeg Jeffrey, 750: EVALUATION OF IV FENTANYL INFUSION DOSE IN THE INTENSIVE CARE UNIT
  51:1, p. 365 - 365 2023
• Critical care medicine
  Swaney Rick, 461: UTILITY OF FUNGAL BIOMARKERS IN CRITICALLY ILL PATIENTS WITH COVID-19 AND FUNGAL COINFECTION
  51:1, p. 218 - 218 2023
• Open forum infectious diseases
  Cooper Stephen J, 956. Improving Understanding and Utilization of the Antibiogram among Medical Residents
  9 2022
• Pharmacy
  Reiche William, Doxycycline Induced Pancreatitis: An Uncommon Complication of a Common Drug
  10:6, p. 144 - 2022
• Chest
  Swaney RICHARD, INCIDENCE, CLINICAL CHARACTERISTICS, AND OUTCOMES OF PATIENTS WITH COVID-19 AND FUNGAL COINFECTION
  162:4, p. A549 - A549 2022
• Antimicrobial Stewardship and Healthcare Epidemiology
  Cooper Stephen J., Improving understanding and utilization of the antibiogram among medical residents
  2:1 2022
• Azeem A., Incidence and Clinical Outcomes of Patients with SARS-CoV-2 Complicated by Pneumothorax and Pneumomediastinum 2022
• Critical care medicine
  Creech Zachary, 219: DISCHARGE DISPOSITION OF COVID-19 PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT
  50:1, p. 94 - 94 2022
• Open forum infectious diseases
  Maxwell Tyler, 1084. Comparative Outcomes Among Patients Receiving Varying Daptomycin Dosing Regimens in Hemodialysis
  8:Supplement_1, p. S633 - S634 2021
• Antibiotics (Basel)
  Reid Eric, Beta-Lactam vs. Fluoroquinolone Monotherapy for
  10:12 2021
• The American journal of gastroenterology
  Aldamen Ali, S3417 Incidence of COVID-19 in Patients With Chronic Hepatitis C in an Outpatient Clinic
  116:1, p. S1404 - S1404 2021
• Chest
  Jackson IAN, PROCALCITONIN AS A PREDICTOR OF CLINICAL OUTCOMES IN PATIENTS WITH COVID-19
  160:4, p. A541 - A541 2021
• Chest
  LYN DELA CRUZ JESSEL, EVALUATION OF THROMBOEMBOLIC EVENTS AND ANTICOAGULANT STRATEGIES IN PATIENTS WITH COVID-19: A RETROSPECTIVE ANALYSIS
  160:4, p. A1114 - A1114 2021
• Critical Care Medicine
  Rajendraprasad Sanu, COVID-19 Therapeutics: What Works?
  49:1, p. 93 - 93 2021
• Critical Care Medicine
  Ahmad Faran, Influence of Health Disparities on COVID-19 Critical Care Admissions
  49:1, p. 101 - 101 2021
• Infectious Disease Reports
  Rajendraprasad Sanu, Mycobacterium avium complex genitourinary infections
  13:2, p. 454 - 464 2021
• Open forum infectious diseases
  Reid Eric C, 129. Beta-lactam vs Fluoroquinolone Monotherapy for pseudomonas Aeruginosa infection: A Systematic Review and Meta-analysis
  7:Supplement_1, p. S194 - S195 2020
• Pharmacy
  Anthone Jennifer, Implementation of a Health-System Wide Antimicrobial Stewardship Program in Omaha, NE
  7:4, p. 156 - 156 2019
• Open forum infectious diseases
  Ased Sumaya J, 2095. Antimicrobial Stewardship (ASP) in Rural and Critical Access Hospitals (CAHs) Using TeleStewardship® Services
  6:Supplement_2, p. S708 - S708 2019
• Open forum infectious diseases
  Destache Christopher J, 2394. A Longitudinal Study of the Effect of Renal Failure on Readmission Rates of Patients with Clostridioides difficile
  6:Supplement_2, p. S826 - S827 2019
• Open forum infectious diseases
  Boldt Dayla, 1069. Implementation and Results of a Health-System Antimicrobial Stewardship (AMS) Program
  6:Supplement_2, p. S379 - S379 2019
• Open forum infectious diseases
  Gummadi Padma Priya, 2691. Comparison of Incidence and Mortality of Kaposi’s Sarcoma Amongst Solid-Organ Transplant Recipients
  6:Supplement_2, p. S945 - S946 2019
• Open forum infectious diseases
  Destache Christopher J, 2501. CCR5 Targeted ARV Loaded Nanoparticle: Dual Protection for HIV Functional Cure
  6:Supplement_2, p. S867 - S868 2019
• Open forum infectious diseases
  George Elizabeth, 1195. Where You Live Matters: United States Region as a Significant Predictor of Mortality for ESBL Infection Based on a Descriptive Study Using NIS Database
  5:suppl_1, p. S361 - S362 2018
• Open forum infectious diseases
  Anthone Jennifer, 527. New Robust Antimicrobial Stewardship Program (ASP) Results in Reduction of Clostridium difficile 30-Day Readmission
  5:Suppl 1, p. S195 - S195 2018
• Open forum infectious diseases
  Cavalieri Stephen, 1808. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) and Vitek 2 Along With Antimicrobial Stewardship (ASP) Result in Faster Antimicrobial Therapy for Infected Patients: The CHI Health Experience
  5:Suppl 1, p. S513 - S513 2018
• Open Forum Infectious Diseases
  Abbas Anum, Health Disparities in HIV and Pregnancy
  5:suppl_1, p. S21 - S21 2018
• Open forum infectious diseases
  Shipley Scott, Evaluation of the Management of ESBL Producing Enterobacteriaceae Infections: CHI health Omaha
  4:suppl_1, p. S151 - S151 2017
• Open forum infectious diseases
  Foral Pamela, A Multicenter Evaluation of Cardiovascular Implantable Electronic Device (CIED) Infection Management
  4:suppl_1, p. S558 - S558 2017
• Open forum infectious diseases
  Foral Pamela, A Novel Vancomycin Standardized Calculations Method Achieved Therapeutic Trough Goals in Obese and Non-obese Patients in a Veterans Affairs Health Care System
  4:suppl_1, p. S293 - S293 2017
• Journal of Nanotechnology and Materials Science
  Shibata Annemarie, Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis
  4:2, p. 53 - 61 2017
• Infection Control and Hospital Epidemiology
  Ased S., Evaluation of Staphylococcus Aureus Bacteremia: Academic and Community-Based Management within the Same Health System
  38:6, p. 740 - 742 2017
• AIDS (London, England)
  Mandal Subhra, Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles for Long-Acting Prevention of HIV-1 Vaginal Transmission
  31:4, p. 469 - 476 2017
• Antimicrobial Agents and Chemotherapy
  Mandal Subhra, An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention Or Treatment of HIV Infection
  61, p. e01475 - 16 2017
• Open forum infectious diseases
  Anthone Jennifer, Impact of Pharmacist-Led Education on Prescribing Habits for Acute Treatment of Suspected Sexually Transmitted Infections (STIs) in an Academic Medical Center Emergency Department (ED)
  3:suppl_1 2016
• Open forum infectious diseases
  Ased Sumaya, A Comparison of Staphylococcus aureus Bacteremia (SAB) Diagnosis and Management: Differences Between Academic and Community Hospital Settings
  3:suppl_1 2016
• iScience Notes
  Destache Christopher J., HIV Latent Reservoir Cure Strategies
  1:1, p. 2 - 2 2016
• Journal of Pharmaceutical and Biomedical Analysis
  Prathipati Pavan K., Simultaneous Quantification of Tenofovir, Emtricitabine, Rilpivirine, Elvitegravir and Dolutegravir in Mouse Biological Matrices by LC-MS/MS and its Application to a Pharmacokinetic Study
  129, p. 473 - 481 2016
• Antimicrobial Agents and Chemotherapy
  Destache Christopher J., Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model
  60:6, p. 3633 - 3639 2016
• Heart (British Cardiac Society)
  Anantha Narayanan M., Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis
  2016, p. (8 pages) - 2016
• Drug Discovery Today
  Date Abhijit A., Natural Polyphenols: Potential in the Prevention of Sexually Transmitted Viral Infections
  21:2, p. 333 - 341 2016
• American journal of respiratory and critical care medicine
  Dhami J, D49 LUNG INFECTION CASE REPORTS II: INFECTIONS OTHER THAN FUNGAL INFECTIONS: Multidrug-Resistant Pseudomonas And Continuous Renal Replacement Therapy: A Case Report And Review Of Literature
  193, p. 1 2016
• The Journal of the American Osteopathic Association
  Foral Pamela A., Education and Communication in an Interprofessional Antimicrobial Stewardship Program
  116:9, p. 588 - 593 2016
• Open forum infectious diseases
  Foral Pamela, 428Incorporating Interprofessional Practice Education and Motivational Interviewing Techniques in Antimicrobial Stewardship Programs at Two Academic Medical Centers
  2:suppl_1, p. S166 - S166 2015
• PLoS Pathogens
  Kovarova M., Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission
  11:8, p. (19 pages) 2015
• AIP Advances
  Mandal Subhra, Confocal fluorescence microscopy: An ultra-sensitive tool used to evaluate intracellular antiretroviral nano-drug delivery in HeLa cells
  5:8, p. (9 pages) 2015
• Biomedical Chromatography
  Date Abhijit A., Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates
  29:5, p. 709 - 715 2015
• International Journal of Stem Cells
  Ahmad H., Direct differentiation of adult ocular progenitors into striatal dopaminergic neurons
  8:1, p. 106 - 114 2015
• Journal of the American Pharmacists Association
  Au Trang H, Hepatitis C Therapy: Looking Toward Interferon-Sparing Regimens
  55:2, p. 209 - 209 2015
• Journal of Pharmacy Practice
  Destache Christopher J., Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature
  27:6, p. 562 - 566 2014
• Clinical Infectious Diseases
  DePestel Daryl D., Assessing Appropriateness of Antimicrobial Therapy: In the Eye of the Interpreter
  59, p. S154 - S161 2014
• Clinical Infectious Diseases
  Hermsen Elizabeth D., Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool
  59:Suppl 3, p. S179 - S184 2014
• Pharmacotherapy
  Dull Ryan B., Antimicrobial Treatment of Asymptomatic Bacteriuria in Noncatheterized Adults: A Systematic Review
  34:9, p. 941 - 960 2014
• Infectious Diseases in Clinical Practice
  Knaak Elizabeth, Does Antibiotic De-Escalation for Nosocomial Pneumonia Impact Intensive Care Unit Length of Stay?
  21:3, p. 172 - 176 2013
• Biomaterials
  Date Abhijit A., A review of nanotechnological approaches for the prophylaxis of HIV/AIDS
  34:26, p. 6202 - 6228 2013
• Antiviral Research
  Date Abhijit A., Development and evaluation of a thermosensitive vaginal gel containing raltegravir + efavirenz loaded nanoparticles for HIV prophylaxis
  96:3, p. 430 - 436 2012
• Nebraska Academy of Sciences, PO Box 880410 Lincoln NE 68588-0410 United States. [np]. Jun 2011
  McMullen Emily, HIV-1 PROTEIN CONCENTRATION AND GENE REGULATION ALTERED UPON TREATMENT WITH ANTIRETROVIRAL NANOPARTICLES 2011
• Clinical Medicine Insights: Therapeutics
  Teply Robyn M., Lopinavir/ritonavir: A Review for 2011
  3, p. 93 - 102 2011
• Journal of Antimicrobial Chemotherapy
  Destache Christopher J., Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice
  65:10, p. 2183 - 2187 2010
• Therapeutic delivery
  Destache Christopher J., Antiretroviral nanoparticles
  1:3, p. 383 - 386 2010
• American Journal of Pharmaceutical Education
  Packard Kathleen A., A tool to teach heart failure treatment guidelines and to assess heart failure therapy in a pharmacy cardiology rotation
  74:6, p. 1 - 7 2010
• Neurochemical Research
  Zhao Min, Role of Prostanoid Production and Receptors in the Regulation of Retinal Endogenous Amino Acid Neurotransmitters by 8-Isoprostaglandin E-2, Ex Vivo
  34:12, p. 2170 - 2180 2009
• Diabetes Spectrum
  Stading Julie, Impact of pharmacist intervention on diabetes patients in an ambulatory setting
  22:4, p. 241 - 246 2009
• Diabetes Educator
  Davis Estella M., Nurse Satisfaction Using Insulin Pens in Hospitalized Patients
  35:5, p. 799 - 809 2009
• Nebraska Academy of Sciences, PO Box 880410 Lincoln NE 68588-0410 United States. [np]. Apr 2009
  Takeshita Shelby, INVESTIGATION OF THE EFFICACY OF NANOPARTICLE ANTIRETROVIRAL DRUG DELIVERY SYSTEMS 2009
• BMC Infectious Diseases
  Destache Christopher J., Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
  9, p. 198 2009
• Hernia
  Turaga K., A randomized trial of the peri-operative use of COX-2 inhibitors in Lichtenstein herniorrhaphy
  12:5, p. 515 - 519 2008
• Shock (Augusta, Ga.)
  Destache Christopher J., ANTIMICROBIAL PHARMACODYNAMICS IN THEORY AND CLINICAL PRACTICE, 2ND EDITION
  29:1, p. 150 2008
• Chest
  Chang Julie A., EFFICACY OF ANTIMICROBIALS FOR ACUTE EXACERBATION OF CHRONIC BRONCHITIS EPISODES
  132:4, p. 530 - 530A 2007
• The FASEB journal
  Opere Catherine Atieno, Effect of isoprostanes on dopamine concentrations in mammalian retinae, in vivo and in vitro
  21:6, p. A1176 - A1176 2007
• Annals of the New York Academy of Sciences
  Gendelman Howard E., Neuroimaging and proteomic tracking of neurodegeneration in MPTP-treated mice
  991, p. 319 - 321 2003
• Chest
  Chock Alan, Outpatient antibiotics in acute exacerbation of chronic bronchitis patients admitted to the hospital
  122:4, p. 161 2002
• Pharmacotherapy
  Nicolau David P., Maximizing Outcomes in Respiratory Tract Infections in the Age of Resistance
  22:1 Part 2, p. 30 - 32S 2002
• Journal of Antimicrobial Chemotherapy
  Destache C. J., Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis
  43:90001, p. 107 - 113 1999
• The Annals of pharmacotherapy
  Destache Christopher J, Notes on Medical Bacteriology. 4Th Edition
  29:11, p. 1176 - 1176 1995
• Medical interface
  Destache C. J., Clinical and economic benefits of a clinical pharmacokinetic service
  7:11, p. 84 - 86, 89 1994
• Destache Christopher J., Economic Aspects of Pharmacokinetic Services 1993
• DICP (Cincinnati, Ohio)
  Mccormack James P., Comment: impact of a kinetic service on aminoglycoside patients
  23:7-8, p. 622 - 622 1989
• The Journal of pharmacy technology
  Destache Christopher J., New Publication: Basic Clinical Pharmacokinetics, 2nd Edition
  5:2, p. 74 - 74 1989
• Drug intelligence & clinical pharmacy
  Destache C. J, Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides from gram-negative infections
  23:1, p. 33 - 38 1989
• Family medicine
  Meyer S. K., A pharmacy fellowship in a family practice training program.
  18:6, p. 394 - 396 1986

Presentations

• Evusheld for Pre-exposure COVDI-19 2023 ID symposium 2023
• HIV drugs. Family Medicine Grand Rounds 2022
• Oral Antivirals for COVID-19 2022 ID Symposium 2022
• A Little of This and Little of That: Finding COVID-19 Therapeutics. 2021 Infectious Diseases Symposium April 24, 2021 2021
• Expanded role of the pharmacist during the COVID-19 pandemic Presented with Dr. Malesker for Rho Chi Society annual summer seminar Zoom meeting June 19, 2020. 2020
• Augmented Renal Clearance: Peeing Antibiotics Fast. Midwest College of Clinical Pharmacy CE meeting. Omaha, NE. January 15, 2020 2020
• Available therapy for resistant Gram-negative bacilli: A changing picture. Presented at the 2019 Infectious Diseases Spring Symposium. CHI Health Creighton University Medical Center-Bergan Mercy April 27, 2019. 2019
• HIV PrEP. Presented at Multi-Cultural Health Science Student Association (MCHSS). Jan 15, 2019. 2019
• Antiretroviral nanoparticles: From PrEP to treatment to functional cure. Nebraska Center for Virology May 4, 2018. 2018
• HIV PrEP: Who, What, When, Why presented at the 2018 Infectious Diseases Symposium CHI Health Bergan Mercy Medical Center April 28. 2018. 2018
• Shipley S, Cavalieri S, Vivekanandan R, Destache CJ. Evaluation of the management of ESBL-producing Enterobacteriaceae infections: CHI Health Omaha. (Abstract 62548) IDWeek San Diego, CA. Oct 7-10, 2017. Presented as a poster. 2017
• Mandal S, Kang G, Prathipati P, Zhou Y, Yuan Z, Fan W, Li Q, Destache C. A comparison study of tenofovir alafenamide (TAF) plus emtricitabine (FTC) in solution and as nanoparticles (NPs) for pre-exposure prophylaxis (PrEP) in humanized BLT (hu-BLT) mice (Abstract WEPEA0194). 9th IAS Conference on HIV Science. Paris, Fr July 23-26, 2017. Presented as a poster. 2017
• Antimicrobial stewardship program. St. Francis Regional Medical Center. 2017
• Antimicrobial stewardship program. St. Francis Regional Medical Center. May 14, 2017 2017
• Antiretroviral nanoparticles for PrEP. NE Center for Virology Inter-Campus Annual Retreat 2017
• Antiretroviral nanoparticles for PrEP. NE Center for Virology Inter-Campus Annual Retreat March 20, 2017. 2017
• Ased S, Vivekanandan R, Anthone J, Rayes H, Dhami J, Cabri A, Davids M, Amosson T, Macaraeg J, Fordjour A, Wilson J, Cavalieri S, Destache C. A Comparison of Staphylococcus aureus Bacteremia (SAB) Diagnosis and Management: Differences Between Academic and Community Hospital Settings. (#1030) IDWeek. New Orleans, LA Oct 26-30, 2016. Presented as a poster. 2016
• "Antiretroviral Nanoparticles for HIV-1 Treatment and Prevention" Biomedical Sciences Department, Creighton University 2016
• "Exploring antiretroviral nanomedicines for treatment and prevention of HIV infection". Invited presentation Department of Pharmacy Sciences, School of Pharmacy, Creighton University. 2016
• Exploring antiretroviral nanomedicines for treatment and prevention of HIV infection. Invited presentation Tulane National Primate Research Center. 2016
• Exploring antiretroviral nanomedicines for treatment and prevention of HIV infection. Invited presentation Tulane National Primate Research Center. September 16, 2016. 2016
• Natural polyphenols: Use against viral STI. Northwest Regional Chemical Society, Anchorage, AK 2016
• Natural polyphenols: Use against viral STI. Northwest Regional Chemical Society, Anchorage, AK June 28, 2016. 2016
• Mandal S, Kang G, Yuan Z, Lu W, Prathipati PK, Li Q, Destache CJ. Combination antiretroviral (cARV) drug loaded nanoparticles (NPs) are efficacious in humanized (HuBLT) mice. (Abstract #SU-408) 2016 ASM-Microbe Conference. Boston, MA Jun 16-20, 2016. Presented as a poster. 2016
• New Antimicrobials. Creighton University Infectious Diseases Symposium. Omaha, NE 2016
• New Antimicrobials. Creighton University Infectious Diseases Symposium. Omaha, NE April 23, 2016. 2016
• Destache CJ, Mandal S, Prathipati PK. TDF/EVG nanoparticle formulation: plasma pharmacokinetics in humanized mice. (Abstract #16-1812) Conference on Retroviruses and Opportunistic Infections. Boston, MA Feb 22-25, 2016. Presented as a poster 2016
• Rapid Viral Respiratory Pathogen Identification. MEDS symposium. Omaha, NE 2014
• Antiretroviral nanoparticles for HIV infection. Presented at the 2014 ACCP Annual Meeting, Austin, TX October 14, 2014. 2014
• HIV Treatment Up-date and Treatment of Hepatitis C. Alaska Pharmacists Association annual meeting. 2014
• Topical tenofovir nanoparticle application prevents HIV-1 vaginal transmission in humanized-BLT mice. Nebraska Center for Virology Annual retreat, Nebraska City, NE 2014
• Evaluation of nanomedicine for HIV treatment and prevention. Distinguished Lecture Series. Texas Tech Center of Excellence in Infectious Diseases, Texas Tech University Health Sciences Center, El Paso, TX 2014
• Cerebrospinal fluid penetration and pharmacokinetics of anti-infective agents. Presented at the 2013 AAPS Annual Meeting and Exposition, San Antonio, TX 2013
• Development of a nanoparticle-based thermosensitive vaginal gel for HIV prevention. 47th American Chemical Society Regional Meeting. Omaha, NE 2012
• In vivo levels of ritonavir, lopinavir, efavirenz over time after intraperitoneal injection of antiretroviral PLGA nanoparticle. Part of the Great 8 abstracts presented at the 30th American College of Clinical Pharmacy meeting. Anaheim, CA 2009
• Assessing Current Threats: Natural and Man-Made. 38th Midyear Clinical Meeting of the American Society for Health-System Pharmacists. New Orleans, LA. 2003
• Statistics in Review. 10th Annual Pediatric Pharmacy Advisory Group Meeting. St. Louis, MO 2001
• Statistics in Review. 10th Annual Pediatric Pharmacy Advisory Group Meeting. St. Louis, MO 2001
• Optimizing Economic Outcomes in Respiratory Tract Infections. Satellite Symposium to the American College of Clinical Pharmacy annual meeting, Los Angeles, CA 2000
• Nitric Oxide Concentrations in S. pneumoniae Meningitis: Correlation to Cytopathology. Presented at the Society of Infectious Diseases Pharmacists Annual Meeting Toronto, Canada 1997
• Economic Evaluation of Clinical Pharmacy Services. Presented at the 1996 American Society of Health System Pharmacists Annual Meeting, San Diego, CA. 1996
• Economic Evaluation of Clinical Pharmacy Services. Presented at the 1995 American Society of Health System Pharmacists Midyear Clinical Meeting, Las Vegas, NV. 1995
• Moderator for Specialty Practice Group in Clinical Pharmacokinetics at the 1993 Midyear Clinical Meeting of the American Society of Hospital Pharmacists, Atlanta, GA. Topic: "Reimbursement Issues for Clinical Pharmacokinetics." 1993
• Does Accepting Pharmacokinetic Recommendations Impact Hospitalization? A Cost-Benefit Analysis. Platform presentation at the American Society of Hospital Pharmacists 24th Midyear Clinical Meeting, Atlanta, GA. 1989
• "Clinical Pharmacokinetics" at the Career Consultation Section of the 24th American Society of Hospital Pharmacists Midyear Clinical Meeting, Atlanta, GA. 1989
• Impact of a Clinical Pharmacokinetic Service on Patients Treated with Aminoglycosides: A Cost-Benefit Analysis. Platform presentation at the 10th Annual American College of Clinical Pharmacy Meeting, Kansas City, MO. 1989
• Inpatient Temperature Monitoring during the Transition of IV to Oral Antibiotics in the Treatment of Pyelonephritis: Is it necessary? Platform presentation at North American Primary Care Research Group Meeting, Seattle, WA. 1985

Other

• Impact of Clinical Microbiology Laboratory Process Optimization on Patient Outcomes with Bloodstream Infections

• Infectious Disease Department PCN Skin Testing

• Infectious Disease Department PCN Skin Testing

Awards

• Department of Medicine Best Fellow Research Award
  2019 Creighton University School of Medicine, Department of Medicine Best Fellow Research Award
  Creighton University School of Medicine
• Scholarly Achievement Award
  Creighton University School of Pharmacy & Allied Health Professions
• Scholarly Achievement Award
  Creighton University School of Pharmacy & Allied Health Professions